TLSI compared with HCAT: revenue, margins and what each company keeps, and the suppliers and customers both name

TLSITriSalus Life Sciences, Inc.

Mkt capRevenueRevenue

HCATHealth Catalyst, Inc.

Mkt capRevenueRevenue

Compare

TLSITriSalus Life Sciences, Inc.

HCATHealth Catalyst, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TLSI

Reportimpliedrealized× implied

Q2 FY26—▲+15.20%—

May 13 '26—▼−41.45%—

Q1 FY26—▼−6.39%—

Jan 12 '26—▲+1.21%—

HCAT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±23.4%▼−25.11%×1.07

May 12 '26±58.0%▲+7.25%×0.13

= impliedTLSI realized, solidHCAT realized, hatchedOne scale, both sides: full bar = 59%× = |realized| ÷ impliedSource: market data

Q1 FY26

±36.1%

▼−26.26%

×0.73

Jan 13 '26±6.1%▼−2.44%×0.39

TLSITriSalus Life Sciences, Inc.

3.55▼−8.65%· post 3.55

Mkt cap$239.5MRevenue$11MQ2 FY26Revenue$45MFY25

HCATHealth Catalyst, Inc.

1.51▼−5.03%· post 1.52

ClosedNov 5 '26

Mkt cap$119.7MRevenue$56MQ3 FY26Revenue$311MFY25

Compare

ClosedNov 5 '26

TLSITriSalus Life Sciences, Inc.

HCATHealth Catalyst, Inc.

3.55▼−8.65%post 3.55

Price

1.51▼−5.03%post 1.52

$239.5M

Mkt cap

$119.7M

Q2 FY26$11M

Revenue

$56MQ3 FY26

FY25$45M

Revenue

$311MFY25

TLSI3.55▼−8.65%vsHCAT1.51▼−5.03%ClosedNov 5 '26